To include your compound in the COVID-19 Resource Center, submit it here.

NICE limits AD drugs

Only patients with moderately severe Alzheimer's disease in England and Wales will be prescribed AD drugs on the U.K.'s

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE